Laura J. Tafe

3.7k total citations
100 papers, 2.2k citations indexed

About

Laura J. Tafe is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Laura J. Tafe has authored 100 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 38 papers in Pulmonary and Respiratory Medicine and 27 papers in Cancer Research. Recurrent topics in Laura J. Tafe's work include Cancer Genomics and Diagnostics (22 papers), Lung Cancer Treatments and Mutations (20 papers) and HER2/EGFR in Cancer Research (8 papers). Laura J. Tafe is often cited by papers focused on Cancer Genomics and Diagnostics (22 papers), Lung Cancer Treatments and Mutations (20 papers) and HER2/EGFR in Cancer Research (8 papers). Laura J. Tafe collaborates with scholars based in United States, Netherlands and Norway. Laura J. Tafe's co-authors include Gregory J. Tsongalis, Robert A. Soslow, Karuna Garg, Maria E. Arcila, Marc Ladanyi, Carmen Tornos, Maureen F. Zakowski, William D. Travis, Mark G. Kris and Natasha Rekhtman and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Laura J. Tafe

93 papers receiving 2.2k citations

Peers

Countries citing papers authored by Laura J. Tafe

Since Specialization

Citations

This map shows the geographic impact of Laura J. Tafe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura J. Tafe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura J. Tafe more than expected).

Fields of papers citing papers by Laura J. Tafe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura J. Tafe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura J. Tafe. The network helps show where Laura J. Tafe may publish in the future.

Co-authorship network of co-authors of Laura J. Tafe

This figure shows the co-authorship network connecting the top 25 collaborators of Laura J. Tafe. A scholar is included among the top collaborators of Laura J. Tafe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura J. Tafe. Laura J. Tafe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical Implementation of Expanded Solid Tumor Fusion Detection With Whole-Transcriptome Sequencing at an Academic Cancer Center 2025 ·JCO Precision Oncology ·Edward G. Hughes, Drew T. Bergman, (unknown), (unknown), Joel A. Lefferts, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Gregory J. Tsongalis, Laura J. Tafe, (unknown)	1
2	Diagnostic next-generation sequencing to detect MYD88 L265P in Lymphoplasmacytic lymphoma compared to ddPCR 2025 ·Experimental and Molecular Pathology ·(unknown), Guohong Huang, (unknown), Gregory J. Tsongalis, Laura J. Tafe, Wahab Khan, Prabhjot Kaur, Parth Shah, (unknown)	1
3	Deep Learning for Grading Endometrial Cancer 2024 ·American Journal Of Pathology ·Manu Goyal, Laura J. Tafe, (unknown), (unknown), (unknown), (unknown), (unknown)	8
4	Angiomyolipomatous Lesions of the Nasal Cavity (Sinonasal Angioleiomyoma with Adipocytic Differentiation): A Multi-Institutional Immunohistochemical and Molecular Study 2024 ·Head and Neck Pathology ·Victoria Jones, Lester D.�R. Thompson, Jason R. Pettus, (unknown), Joel A. Lefferts, Parth Shah, Gregory J. Tsongalis, Dipti P. Sajed, Julie Guilmette, James S. Lewis, Adam S. Fisch, Laura J. Tafe, Darcy A. Kerr	0
5	Validation and Implementation of a Somatic-Only Tumor Exome for Routine Clinical Application 2024 ·Journal of Molecular Diagnostics ·Parth Shah, Edward G. Hughes, (unknown), (unknown), (unknown), Gregory J. Tsongalis, Laura J. Tafe	9
6	Fluorescence molecular optomic signatures improve identification of tumors in head and neck specimens 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Brady Hunt, (unknown), Jason R. Gunn, Laura J. Tafe, Joseph A. Paydarfar, Brian W. Pogue, Keith D. Paulsen, Kimberley S. Samkoe	1
7	Utility of Retrospective Molecular Analysis in Diagnostically Challenging Mesenchymal Neoplasms 2023 ·International Journal of Surgical Pathology ·(unknown), Laura J. Tafe, (unknown), Sophie J. Deharvengt, (unknown), Gregory J. Tsongalis, Michael Baker, Konstantinos Linos, Joshua Levy, Darcy A. Kerr	2
8	Recommendations for Cell-Free DNA Assay Validations 2023 ·Journal of Molecular Diagnostics ·Christina M. Lockwood, Laetitia Borsu, Milena Cankovic, (unknown), Christopher D. Gocke, Meera Hameed, (unknown), Jean Lopategui, (unknown), Jacquelyn Reuther, Kandelaria M. Rumilla, Laura J. Tafe, Robyn Temple‐Smolkin, (unknown), Apostolia M. Tsimberidou	30
9	Primary Pulmonary Round Cell Sarcomas: Multiple Potential Pitfalls for the Pathologist 2022 ·International Journal of Surgical Pathology ·(unknown), George Jour, Laura J. Tafe, André Pinto, Iva Brčić, Konstantinos Linos, Darcy A. Kerr	4
10	Cross-reactivity of NRASQ61R antibody in a subset of Spitz nevi with 11p gain: a potential confounding factor in the era of pathway-based diagnostic approach 2021 ·Human Pathology ·(unknown), Joel A. Lefferts, Laura J. Tafe, Alejandro A. Gru, Konstantinos Linos	4
11	Using molecular testing to improve the management of thyroid nodules with indeterminate cytology: an institutional experience with review of molecular alterations 2021 ·Journal of the American Society of Cytopathology ·(unknown), Jonathan D. Marotti, Darcy A. Kerr, Joshua Levy, Louis Vaickus, Edward J. Gutmann, Laura J. Tafe, Samaneh Motanagh, Meredith J. Sorensen, Louise Davies, Xiaoying Liu	16
12	Primary cutaneous Ewing sarcoma with diffuse S100/SOX10 positivity and pseudoalveolar pattern: An extraordinarily rare case highlighting a potential pitfall with significant repercussions 2020 ·Journal of Cutaneous Pathology ·(unknown), Linsheng Zhang, Laura J. Tafe, (unknown), Zakaria Grada, Konstantinos Linos	7
13	Pathologic Features and Clinical Implications of Breast Cancer With HER2 Intratumoral Genetic Heterogeneity 2019 ·American Journal of Clinical Pathology ·Kristen E. Muller, Jonathan D. Marotti, Laura J. Tafe	18
14	Isocitrate dehydrogenase 1 mutations in melanoma frequently co‐occur with NRAS mutations 2018 ·Histopathology ·Konstantinos Linos, Laura J. Tafe	20
15	Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer 2017 ·Molecular Cancer Research ·Lisa Maria Mustachio, Yun Lu, Laura J. Tafe, Vincent A. Memoli, Jaime Rodriguez‐Canales, Barbara Mino, Pamela Villalobos, Ignacio I. Wistuba, Hiroyuki Katayama, Samir Hanash, Jason Roszik, Masanori Kawakami, Kwang-Jin Cho, John F. Hancock, (unknown), Shanhu Hu, Xi Liu, Sarah J. Freemantle, Ethan Dmitrovsky	34
16	Evaluating melanocytic lesions with single nucleotide polymorphism (SNP) chromosomal microarray 2017 ·Experimental and Molecular Pathology ·A. Hedayat, Konstantinos Linos, Hou-Sung Jung, Laura J. Tafe, Shaofeng Yan, Robert E. LeBlanc, Joel A. Lefferts	9
17	Highly accurate molecular genetic testing for HFE hereditary hemochromatosis: results from 10 years of blinded proficiency surveys by the College of American Pathologists 2016 ·Genetics in Medicine ·Richard D. Press, (unknown), Thomas J. McDonald, (unknown), Thomas Long, Laura J. Tafe, Karen E. Weck	4
18	Molecular testing for the BRCA1 and BRCA2 Ashkenazi Jewish founder mutations: a report on the College of American Pathologists proficiency testing surveys 2014 ·Genetics in Medicine ·Laura J. Tafe, Michael Datto, Glenn E. Palomaki, Felicitas Lacbawan	13
19	Clarifying the Spectrum of Driver Oncogene Mutations in Biomarker-Verified Squamous Carcinoma of Lung: Lack of EGFR / KRA S and Presence of PIK3CA / AKT1 Mutations 2012 ·Clinical Cancer Research ·Natasha Rekhtman, Paul K. Paik, Maria E. Arcila, Laura J. Tafe, Geoffrey R. Oxnard, André L. Moreira, William D. Travis, Maureen F. Zakowski, Mark G. Kris, Marc Ladanyi	289
20	Detection of the C282Y and H63D Polymorphisms Associated With Hereditary Hemochromatosis Using the ABI 7500 FAST Real Time PCR Platform 2007 ·Diagnostic Molecular Pathology ·Laura J. Tafe, Dorothy R. Belloni, Gregory J. Tsongalis	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact